Cancer · 1967 · 22 citations · 8 references
MedicineNeurosurgeryRadiologyBiomedical ImagingDiagnostic ImagingDiagnostic RadiologyBrain TumorsCancer DetectionNeuro-oncologic ImagingTumor DetectionTumor ImagingTumor MarkersBrain Tumor DiagnosisFalse Information DetectionTumor Localization
Two of the most promising isotopically labeled compounds for the localization of intracranial tumors by photoscanning are compared. 203Hg-neohydrin and 131I-labeled antibody to human fibrinogen are equal in effectiveness in localizing known tumors in the cranium, and they introduce approximately the same proportion of false information. 203Hg-neohydrin is more convenient: it is commercially available. Furthermore, scans can be performed as early as four hours after its administration, whereas an interval of at least 40 hours is necessary following the administration of 131I-labeled antibody before scanning can be efficiently undertaken, because of the slow clearance of this agent from the blood. A 44 to 48 hour interval was used for 131I-labeled antibody in this study. 131I-antibody is effective for detecting tumors outside the cranium. For tumors inside the cranium this localization technique with either agent has been found to be extremely useful in neurosurgical care.
8
High specific activity iodination of gamma-globulin with iodine-131 monochloride.
R. W. Helmkamp, Ruth L. Goodland, William F. Bale et al. · PubMed · 1960 · 323 citations
131I-labeled antibodies to human fibrinogen.Diagnostic studies and therapeutic trials
Irving L. Spar, William F. Bale, David Marrack et al. · Cancer · 1967 · 83 citations · Full text
Medicine, Oncology, Pharmacology +13
Brain Scans in Neoplastic Intracranial Lesions
Marvin C. Overton · JAMA · 1965 · 47 citations